PharmaForce to Invest $145 Million in Facilities Expansion
The company will expand two of its Ohio facilities, investing approximately $145 million to support manufacturing and warehouse operations.
PharmaForce, a privately held R&D and manufacturing company, announced its $145-million investment to expand two of its Ohio facilities on Dec. 4, 2017. The company will add approximately 140,000 ft2 to its New Albany, OH, facility to expand manufacturing and warehouse operations, as well as remodel a section of its existing warehouse and production space in Hilliard, OH. The company will add 1800 ft2 to the Hilliard site, with plans to invest in new production equipment and supporting infrastructure.
Construction and remodeling will start in 2018, with hiring for packaging, mechanical, sterile, quality assurance, and validation positions beginning in the first quarter of 2018 for the New Albany facility and in late 2018 for the Hilliard facility. Between the two facilities, 80 jobs will be created.
“Our operations in New Albany and Hilliard have played a critical role in the growth of our company, and the investment in our manufacturing, warehouse and R&D capabilities supports that growth,” said PharmaForce Dante Serricchio, vice president and general manager, in a press release from the economic development organization, Columbus 2020.
Source: Columbus 2020
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
